REGN vs VFC · P/E 14, rev $14.34B vs P/E 26, rev $9.50B
Regeneron Pharmaceuticals Inc (REGN) versus VF Corporation (VFC) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
VF Corporation (VFC) is a apparel manufacturing company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported VFC revenue for 2025-03-29 was $9.50B. Net income was -$189.7M. Revenue was down 4.1% from 2024-03-30 to 2025-03-29. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
Not investment advice. Open the REGN and VFC stock pages for the full models.
Not investment advice.